Aehr Test Systems Logo

Aehr Test Systems

AEHR

(2.8)
Stock Price

12,98 USD

17.68% ROA

26.97% ROE

27.45x PER

Market Cap.

514.976.490,00 USD

7.83% DER

0% Yield

25.76% NPM

Aehr Test Systems Stock Analysis

Aehr Test Systems Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aehr Test Systems Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (23.07%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (8%), which means it has a small amount of debt compared to the ownership it holds

4 Net Profit Growth

Over the last five years, this company's net profit has shown continuous growth, reflecting a robust financial performance and making it an attractive choice for potential investors.

5 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

6 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (9.48x) suggests it's overvalued, potentially making it an expensive investment.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-22) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Aehr Test Systems Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aehr Test Systems Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Aehr Test Systems Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aehr Test Systems Revenue
Year Revenue Growth
1997 42.000.000
1998 40.805.000 -2.93%
1999 18.146.000 -124.87%
2000 24.505.000 25.95%
2001 31.039.000 21.05%
2002 12.568.000 -146.97%
2003 15.092.000 16.72%
2004 15.800.000 4.48%
2005 16.080.000 1.74%
2006 23.801.000 32.44%
2007 27.351.000 12.98%
2008 39.041.000 29.94%
2009 21.407.000 -82.37%
2010 11.674.000 -83.37%
2011 13.737.000 15.02%
2012 15.521.000 11.49%
2013 16.488.000 5.86%
2014 19.684.000 16.24%
2015 10.018.000 -96.49%
2016 14.501.000 30.92%
2017 18.898.000 23.27%
2018 29.555.000 36.06%
2019 21.056.000 -40.36%
2020 22.291.000 5.54%
2021 16.600.000 -34.28%
2022 50.829.000 67.34%
2023 64.961.000 21.75%
2024 82.496.000 21.26%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aehr Test Systems Research and Development Expenses
Year Research and Development Expenses Growth
1997 3.700.000
1998 3.629.000 -1.96%
1999 3.685.000 1.52%
2000 4.501.000 18.13%
2001 4.382.000 -2.72%
2002 4.036.000 -8.57%
2003 4.543.000 11.16%
2004 4.645.000 2.2%
2005 4.023.000 -15.46%
2006 4.339.000 7.28%
2007 6.324.000 31.39%
2008 6.501.000 2.72%
2009 5.762.000 -12.83%
2010 4.758.000 -21.1%
2011 4.567.000 -4.18%
2012 4.188.000 -9.05%
2013 3.211.000 -30.43%
2014 3.402.000 5.61%
2015 4.062.000 16.25%
2016 4.324.000 6.06%
2017 4.657.000 7.15%
2018 4.181.000 -11.38%
2019 4.153.000 -0.67%
2020 3.386.000 -22.65%
2021 3.652.000 7.28%
2022 5.818.000 37.23%
2023 7.134.000 18.45%
2024 9.828.000 27.41%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aehr Test Systems General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aehr Test Systems EBITDA
Year EBITDA Growth
1997 4.900.000
1998 5.042.000 2.82%
1999 -4.620.000 209.13%
2000 -4.988.000 7.38%
2001 2.025.000 346.32%
2002 -3.798.000 153.32%
2003 -3.996.000 4.95%
2004 -4.418.000 9.55%
2005 -4.738.000 6.75%
2006 716.000 761.73%
2007 413.000 -73.37%
2008 6.356.000 93.5%
2009 -24.560.000 125.88%
2010 -197.000 -12367.01%
2011 -4.376.000 95.5%
2012 -4.016.000 -8.96%
2013 -2.982.000 -34.67%
2014 621.000 580.19%
2015 -6.348.000 109.78%
2016 -5.967.000 -6.39%
2017 -4.679.000 -27.53%
2018 854.000 647.89%
2019 -3.550.000 124.06%
2020 -2.325.000 -52.69%
2021 -6.368.000 63.49%
2022 6.102.000 204.36%
2023 13.375.000 54.38%
2024 17.012.000 21.38%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aehr Test Systems Gross Profit
Year Gross Profit Growth
1997 16.900.000
1998 16.446.000 -2.76%
1999 5.945.000 -176.64%
2000 7.238.000 17.86%
2001 13.116.000 44.82%
2002 6.080.000 -115.72%
2003 5.738.000 -5.96%
2004 5.708.000 -0.53%
2005 4.263.000 -33.9%
2006 10.636.000 59.92%
2007 13.913.000 23.55%
2008 19.969.000 30.33%
2009 1.184.000 -1586.57%
2010 6.103.000 80.6%
2011 5.512.000 -10.72%
2012 6.207.000 11.2%
2013 6.776.000 8.4%
2014 10.222.000 33.71%
2015 3.838.000 -166.34%
2016 5.145.000 25.4%
2017 6.780.000 24.12%
2018 12.386.000 45.26%
2019 7.602.000 -62.93%
2020 8.371.000 9.19%
2021 6.032.000 -38.78%
2022 23.665.000 74.51%
2023 32.746.000 27.73%
2024 39.924.000 17.98%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aehr Test Systems Net Profit
Year Net Profit Growth
1997 3.300.000
1998 2.405.000 -37.21%
1999 -2.330.000 203.22%
2000 -2.605.000 10.56%
2001 -141.000 -1747.52%
2002 -5.267.000 97.32%
2003 -4.544.000 -15.91%
2004 -3.959.000 -14.78%
2005 -4.870.000 18.71%
2006 810.000 701.23%
2007 2.428.000 66.64%
2008 10.573.000 77.04%
2009 -29.971.000 135.28%
2010 -481.000 -6130.98%
2011 -3.373.000 85.74%
2012 -3.389.000 0.47%
2013 -3.419.000 0.88%
2014 422.000 910.19%
2015 -6.647.000 106.35%
2016 -6.785.000 2.03%
2017 -5.653.000 -20.02%
2018 528.000 1170.64%
2019 -5.235.000 110.09%
2020 -2.802.000 -86.83%
2021 -2.027.000 -38.23%
2022 9.450.000 121.45%
2023 14.557.000 35.08%
2024 18.696.000 22.14%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aehr Test Systems Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 1
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 -1 0%
2003 -1 0%
2004 -1 0%
2005 -1 0%
2006 0 0%
2007 0 0%
2008 1 100%
2009 -4 133.33%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 -1 0%
2016 -1 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 1 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aehr Test Systems Free Cashflow
Year Free Cashflow Growth
1997 2.400.000
1998 -979.000 345.15%
1999 -413.000 -137.05%
2000 -7.313.000 94.35%
2001 889.000 922.61%
2002 -1.180.000 175.34%
2003 -4.076.000 71.05%
2004 -959.000 -325.03%
2005 -2.839.000 66.22%
2006 1.352.000 309.99%
2007 -2.212.000 161.12%
2008 2.568.000 186.14%
2009 -12.149.000 121.14%
2010 3.178.000 482.28%
2011 -4.157.000 176.45%
2012 -4.920.000 15.51%
2013 -437.000 -1025.86%
2014 -946.000 53.81%
2015 -2.374.000 60.15%
2016 -7.200.000 67.03%
2017 -4.972.000 -44.81%
2018 -1.923.000 -158.55%
2019 -5.810.000 66.9%
2020 -2.187.000 -165.66%
2021 -2.928.000 25.31%
2022 1.092.000 368.13%
2023 8.649.000 87.37%
2024 3.617.000 -139.12%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aehr Test Systems Operating Cashflow
Year Operating Cashflow Growth
1997 3.000.000
1998 -664.000 551.81%
1999 342.000 294.15%
2000 -5.956.000 105.74%
2001 1.011.000 689.12%
2002 -226.000 547.35%
2003 -3.815.000 94.08%
2004 -800.000 -376.88%
2005 -2.543.000 68.54%
2006 1.501.000 269.42%
2007 -1.109.000 235.35%
2008 3.624.000 130.6%
2009 -11.036.000 132.84%
2010 3.247.000 439.88%
2011 -4.142.000 178.39%
2012 -4.875.000 15.04%
2013 -310.000 -1472.58%
2014 -607.000 48.93%
2015 -2.256.000 73.09%
2016 -6.281.000 64.08%
2017 -4.495.000 -39.73%
2018 -1.351.000 -232.72%
2019 -5.637.000 76.03%
2020 -2.024.000 -178.51%
2021 -2.701.000 25.06%
2022 1.508.000 279.11%
2023 10.011.000 84.94%
2024 3.901.000 -156.63%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aehr Test Systems Capital Expenditure
Year Capital Expenditure Growth
1997 600.000
1998 315.000 -90.48%
1999 755.000 58.28%
2000 1.357.000 44.36%
2001 122.000 -1012.3%
2002 954.000 87.21%
2003 261.000 -265.52%
2004 159.000 -64.15%
2005 296.000 46.28%
2006 149.000 -98.66%
2007 1.103.000 86.49%
2008 1.056.000 -4.45%
2009 1.113.000 5.12%
2010 69.000 -1513.04%
2011 15.000 -360%
2012 45.000 66.67%
2013 127.000 64.57%
2014 339.000 62.54%
2015 118.000 -187.29%
2016 919.000 87.16%
2017 477.000 -92.66%
2018 572.000 16.61%
2019 173.000 -230.64%
2020 163.000 -6.13%
2021 227.000 28.19%
2022 416.000 45.43%
2023 1.362.000 69.46%
2024 284.000 -379.58%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aehr Test Systems Equity
Year Equity Growth
1997 10.100.000
1998 39.964.000 74.73%
1999 36.678.000 -8.96%
2000 34.305.000 -6.92%
2001 34.807.000 1.44%
2002 29.885.000 -16.47%
2003 25.345.000 -17.91%
2004 22.204.000 -14.15%
2005 17.452.000 -27.23%
2006 18.817.000 7.25%
2007 22.668.000 16.99%
2008 37.772.000 39.99%
2009 9.963.000 -279.12%
2010 11.281.000 11.68%
2011 9.101.000 -23.95%
2012 6.454.000 -41.01%
2013 5.014.000 -28.72%
2014 7.050.000 28.88%
2015 4.568.000 -54.33%
2016 -703.000 749.79%
2017 16.813.000 104.18%
2018 19.305.000 12.91%
2019 15.453.000 -24.93%
2020 14.056.000 -9.94%
2021 11.449.000 -22.77%
2022 50.989.000 77.55%
2023 75.600.000 32.55%
2024 80.145.000 5.67%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aehr Test Systems Assets
Year Assets Growth
1997 24.400.000
1998 47.105.000 48.2%
1999 41.187.000 -14.37%
2000 40.729.000 -1.12%
2001 39.592.000 -2.87%
2002 33.818.000 -17.07%
2003 28.247.000 -19.72%
2004 26.812.000 -5.35%
2005 21.469.000 -24.89%
2006 24.893.000 13.75%
2007 28.675.000 13.19%
2008 45.199.000 36.56%
2009 13.911.000 -224.92%
2010 14.474.000 3.89%
2011 12.083.000 -19.79%
2012 11.613.000 -4.05%
2013 10.975.000 -5.81%
2014 12.225.000 10.22%
2015 14.868.000 17.78%
2016 10.046.000 -48%
2017 30.892.000 67.48%
2018 30.955.000 0.2%
2019 21.307.000 -45.28%
2020 20.574.000 -3.56%
2021 21.665.000 5.04%
2022 62.328.000 65.24%
2023 98.143.000 36.49%
2024 105.469.000 6.95%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aehr Test Systems Liabilities
Year Liabilities Growth
1997 14.300.000
1998 7.141.000 -100.25%
1999 4.509.000 -58.37%
2000 6.424.000 29.81%
2001 4.785.000 -34.25%
2002 3.933.000 -21.66%
2003 2.902.000 -35.53%
2004 4.608.000 37.02%
2005 4.017.000 -14.71%
2006 6.076.000 33.89%
2007 6.007.000 -1.15%
2008 7.427.000 19.12%
2009 3.948.000 -88.12%
2010 3.193.000 -23.65%
2011 2.982.000 -7.08%
2012 5.159.000 42.2%
2013 5.981.000 13.74%
2014 5.196.000 -15.11%
2015 10.318.000 49.64%
2016 10.769.000 4.19%
2017 14.098.000 23.61%
2018 11.670.000 -20.81%
2019 5.854.000 -99.35%
2020 6.518.000 10.19%
2021 10.216.000 36.2%
2022 11.339.000 9.9%
2023 22.543.000 49.7%
2024 25.324.000 10.98%

Aehr Test Systems Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.61
Net Income per Share
0.65
Price to Earning Ratio
27.45x
Price To Sales Ratio
6.87x
POCF Ratio
60.56
PFCF Ratio
74.75
Price to Book Ratio
6.39
EV to Sales
6.28
EV Over EBITDA
27.39
EV to Operating CashFlow
55.65
EV to FreeCashFlow
68.27
Earnings Yield
0.04
FreeCashFlow Yield
0.01
Market Cap
0,51 Bil.
Enterprise Value
0,47 Bil.
Graham Number
6.4
Graham NetNet
1.79

Income Statement Metrics

Net Income per Share
0.65
Income Quality
0.45
ROE
0.27
Return On Assets
0.21
Return On Capital Employed
0.2
Net Income per EBT
1
EBT Per Ebit
1.11
Ebit per Revenue
0.23
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.11
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.51
Operating Profit Margin
0.23
Pretax Profit Margin
0.26
Net Profit Margin
0.26

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.29
Free CashFlow per Share
0.24
Capex to Operating CashFlow
-0.18
Capex to Revenue
-0.02
Capex to Depreciation
-3.13
Return on Invested Capital
0.18
Return on Tangible Assets
0.18
Days Sales Outstanding
64.12
Days Payables Outstanding
82.9
Days of Inventory on Hand
314.12
Receivables Turnover
5.69
Payables Turnover
4.4
Inventory Turnover
1.16
Capex per Share
-0.05

Balance Sheet

Cash per Share
1,78
Book Value per Share
2,80
Tangible Book Value per Share
2.8
Shareholders Equity per Share
2.8
Interest Debt per Share
0.19
Debt to Equity
0.08
Debt to Assets
0.06
Net Debt to EBITDA
-2.6
Current Ratio
5
Tangible Asset Value
0,08 Bil.
Net Current Asset Value
0,07 Bil.
Invested Capital
0.08
Working Capital
0,08 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
27732500
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aehr Test Systems Dividends
Year Dividends Growth

Aehr Test Systems Profile

About Aehr Test Systems

Aehr Test Systems provides test systems for burning-in and testing logic, optical, and memory integrated circuits worldwide. It offers products, such as the ABTS and FOX-P families of test and burn-in systems and FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for lower power and higher power logic devices, as well as various common types of memory devices. The FOX-XP and FOX-NP systems are wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a single-wafer compact test and reliability verification solution for logic, memory, and photonic devices. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules. Aehr Test Systems was incorporated in 1977 and is headquartered in Fremont, California.

CEO
Mr. Gayn Erickson
Employee
104
Address
400 Kato Terrace
Fremont, 94539

Aehr Test Systems Executives & BODs

Aehr Test Systems Executives & BODs
# Name Age
1 Mr. Donald P. Richmond II
Chief Technology Officer
70
2 Dr. Avijit K. Ray-Chaudhuri
Executive Vice President of R&D
70
3 Mr. Rhea J. Posedel
Founder & Independent Chairman
70
4 Mr. Vernon Rogers
Executive Vice President of Sales & Marketing
70
5 Mr. Gayn Erickson
President, Chief Executive Officer & Director
70
6 Mr. Chris P. Siu
Chief Financial Officer, Executive Vice President of Finance & Secretary
70
7 Mr. Adil Engineer
Chief Operating Officer
70

Aehr Test Systems Competitors